AI

El Agente F\'armaco: A Scalable AI Scientist for Drug Discovery

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 04/11/2026, 05:18:24 UTC.

Briefings

El Agente F\'armaco is an AI scientist that converts natural language drug discovery goals into scalable computational workflows using large language models. It manages scientific tools, reviews results, and adjusts steps based on user objectives, with a shared memory called F\'armaco Atlas storing molecules and provenance. A single request can launch calculations for entire collections without per-compound LLM decisions, improving efficiency. In a 22-task benchmark against plain tool calls and Codex, the agent achieved the highest observed mean model-judged score, using lower median cumulative tokens and peak context compared to baseline methods.

Key points

• El Agente F\'armaco uses large language models to translate natural language drug discovery goals into scalable computational workflows.
• The agent manages scientific tools, reviews results, and adjusts steps based on user objectives, with a shared memory called F\'armaco Atlas storing molecules and provenance.

Context

Computational drug discovery tools exist but require substantial expert effort to combine and decide on next steps. El Agente F\'armaco addresses this by using an agentic harness to select tools, review results, and adjust steps, centered on a shared scientific memory called F\'armaco Atlas.

Limitations

The evidence is from an arXiv preprint (arXiv:2611.03832v1) and includes retrospective comparisons and benchmark results. Specific causal claims about the agent's superiority over all methods are limited to the reported 22-task benchmark results. The study compares against plain tool calls and Codex, but does not provide data on other potential agents or alternative evaluation metrics.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 04/11/2026, 08:06:51 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeib46jl73icw2mp3hg3ejre27fznezhaeqjzusrvtj2zec6zn3wo7m